Bioline Rx reported $831K in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Arca Biopharma USD 2.23M 1.08M Dec/2025
Bio Path USD 199K 300K Sep/2025
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 1.92M 446.47K Dec/2025